Compositions and methods for the treatment of cancer
The instant invention provides methods and compositions for the treatment and diagnosis of cancer, e.g., cancers characterized by the expression of prostate specific membrane antigen (PSMA).
1. An isolated peptide comprising WQPDTAHHWATL (SEQ ID NO:1), wherein the peptide is capable of binding to PSMA.
2. The isolated peptide of claim 1 , wherein the peptide consists of the amino acid set forth as SEQ ID NO:1.
3. The isolated peptide of claim 1 , wherein the peptide further comprises the second amino acid sequence set forth as SEQ ID NO:1.
4. The isolated peptide of claim 1 , further comprising one or more additional amino acid sequences set forth as SEQ ID NOs: 2-17.
5. The isolated peptide of claim 1 , wherein the peptide is linked to an imaging agent.
6. The isolated peptide of claim 5 , wherein the imaging agent is a radiolabel.
7. An isolated peptide comprising a first amino acid sequence as set forth in SEQ ID NO:1 and a second amino acid sequence as set forth in SEQ ID NO:1, wherein the first and second amino acid sequences are connected by a linker, and wherein the peptide is capable of binding to PSMA.
8. An isolated peptide comprising SEQ ID NO: 1 and a second amino acid sequence selected from the group consisting of SEQ ID NO: 2-17, wherein the first and second amino acid sequences are connected by a linker, wherein the peptide is capable of binding to PSMA.
9. The isolated peptide of claim 8 , wherein the linker is an amino acid, peptide, chemical moiety, diamine, or polyglycol.
10. A composition comprising the isolated peptide of claim 1 and a carrier.
11. A kit comprising the isolated peptide of claim 1 and instructions for use.
12. A kit for determining if a subject has a prostate cancer comprising the isolated peptide of claim 5 , and instructions for use.